Serina Therapeutics (SER) FCF Margin Growth (3y) (2021 - 2025)
Serina Therapeutics (SER) FCF Margin Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | -3,088.00 |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.16 Mn |
| Dec 31, 2024 | 3.39 Mn |
| Sep 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.09 Mn |
| Mar 31, 2024 | -2.73 Mn |
| Dec 31, 2023 | 114,785.00 |
| Sep 30, 2023 | -130,805.00 |
| Jun 30, 2023 | -716,063.00 |
| Mar 31, 2023 | -3,974.00 |
| Dec 31, 2022 | -1.60 Mn |
| Sep 30, 2022 | -1.31 Mn |
| Jun 30, 2022 | -1.38 Mn |
| Mar 31, 2022 | -3.20 Mn |
| Dec 31, 2021 | -17,629.00 |
| Sep 30, 2021 | -700,368.00 |
| Jun 30, 2021 | -435,330.00 |